Emília Hardak

647 total citations
33 papers, 450 citations indexed

About

Emília Hardak is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Emília Hardak has authored 33 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Infectious Diseases. Recurrent topics in Emília Hardak's work include Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Fungal Infections and Studies (8 papers) and Antifungal resistance and susceptibility (7 papers). Emília Hardak is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Fungal Infections and Studies (8 papers) and Antifungal resistance and susceptibility (7 papers). Emília Hardak collaborates with scholars based in Israel, United States and France. Emília Hardak's co-authors include Mordechai Yigla, Ilana Oren, Olga R. Brook, Gidon Berger, Hannah Sprecher, Irit Avivi, Yuval Geffen, Tsila Zuckerman, Renato Finkelstein and Noa Lavi and has published in prestigious journals such as Clinical Infectious Diseases, Thorax and Lara D. Veeken.

In The Last Decade

Emília Hardak

32 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emília Hardak Israel 13 277 172 143 52 50 33 450
O. Baron Israel 8 128 0.5× 97 0.6× 199 1.4× 14 0.3× 42 0.8× 35 425
Yuji Shiraishi Japan 17 541 2.0× 439 2.6× 288 2.0× 34 0.7× 256 5.1× 52 925
Qian He China 11 175 0.6× 194 1.1× 87 0.6× 3 0.1× 40 0.8× 40 410
F Sadr Iran 11 84 0.3× 105 0.6× 68 0.5× 5 0.1× 34 0.7× 19 341
Yousuke Miyahara Japan 8 260 0.9× 199 1.2× 126 0.9× 5 0.1× 118 2.4× 18 379
Takemasa Matsumoto Japan 9 82 0.3× 54 0.3× 138 1.0× 6 0.1× 22 0.4× 30 281
John P. DiTomasso United States 10 199 0.7× 176 1.0× 33 0.2× 8 0.2× 59 1.2× 12 426
Surajit Nayak India 6 85 0.3× 101 0.6× 15 0.1× 16 0.3× 29 0.6× 20 361
Sofya Tokman United States 10 175 0.6× 57 0.3× 110 0.8× 14 0.3× 9 0.2× 44 390
Basanti Acharjya India 6 83 0.3× 99 0.6× 15 0.1× 16 0.3× 29 0.6× 15 357

Countries citing papers authored by Emília Hardak

Since Specialization
Citations

This map shows the geographic impact of Emília Hardak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emília Hardak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emília Hardak more than expected).

Fields of papers citing papers by Emília Hardak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emília Hardak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emília Hardak. The network helps show where Emília Hardak may publish in the future.

Co-authorship network of co-authors of Emília Hardak

This figure shows the co-authorship network connecting the top 25 collaborators of Emília Hardak. A scholar is included among the top collaborators of Emília Hardak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emília Hardak. Emília Hardak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yaari, Shlomit, Lisa Kaly, Itzhak Rosner, et al.. (2025). Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in SSc: a real-world national cohort study. Lara D. Veeken. 65(2). 1 indexed citations
2.
Hardak, Emília, et al.. (2025). Chronic lymphocytic leukemia and associated chronic lung diseases. Haematologica. 110(11). 2673–2682.
3.
Wolak, Arik, Emília Hardak, Gleb Slobodin, et al.. (2024). Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis—a two-step approach. Lara D. Veeken. 63(12). e328–e330. 1 indexed citations
4.
Hardak, Emília, et al.. (2019). Heparan sulfate chains contribute to the anticoagulant milieu in malignant pleural effusion. Thorax. 75(2). 143–152. 7 indexed citations
5.
Dragu, Robert, et al.. (2019). Prognostic value and diagnostic properties of the diastolic pulmonary pressure gradient in patients with pulmonary hypertension and left heart disease. International Journal of Cardiology. 290. 138–143. 10 indexed citations
7.
Bitterman, Roni, Emília Hardak, Anat Stern, et al.. (2019). Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort Study. Clinical Infectious Diseases. 69(10). 1805–1808. 21 indexed citations
8.
Aronson, Doron, Emília Hardak, & Andrew J. Burger. (2018). Hemodynamics of the diastolic pressure gradients in acute heart failure: implications for the diagnosis of pre‐capillary pulmonary hypertension in left heart disease. Pulmonary Circulation. 9(1). 1–9. 6 indexed citations
9.
Lavi, Noa, et al.. (2018). Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma. Supportive Care in Cancer. 26(7). 2425–2431. 7 indexed citations
10.
Balbir‐Gurman, Alexandra, Ludmila Guralnik, Mordechai Yigla, Yolanda Braun‐Moscovici, & Emília Hardak. (2017). Imaging aspects of interstitial lung disease in patients with rheumatoid arthritis: Literature review. Autoimmunity Reviews. 17(2). 87–93. 26 indexed citations
11.
Oren, Ilana, Emília Hardak, Tsila Zuckerman, et al.. (2016). Does molecular analysis increase the efficacy of bronchoalveolar lavage in the diagnosis and management of respiratory infections in hemato-oncological patients?. International Journal of Infectious Diseases. 50. 48–53. 13 indexed citations
12.
Hardak, Emília, Irit Avivi, Ayelet Raz‐Pasteur, et al.. (2016). Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome. Infection. 44(4). 491–497. 37 indexed citations
13.
Raz‐Pasteur, Ayelet, et al.. (2015). Do Wound Cultures Give Information About the Microbiology of Blood Cultures in Severe Burn Patients?. Annals of Plastic Surgery. 76(1). 34–39. 4 indexed citations
14.
Hardak, Emília, Mordechai Yigla, Gidon Berger, Hannah Sprecher, & Ilana Oren. (2011). Clinical Spectrum and Outcome of Nocardia Infection: Experience of 15-Year Period From a Single Tertiary Medical Center. The American Journal of the Medical Sciences. 343(4). 286–290. 50 indexed citations
15.
Oren, Ilana, Renato Finkelstein, Emília Hardak, Hannah Sprecher, & Mordechai Yigla. (2011). Polymerase Chain Reaction-Based Detection of Pneumocystis jirovecii in Bronchoalveolar Lavage Fluid for the Diagnosis of Pneumocystis Pneumonia. The American Journal of the Medical Sciences. 342(3). 182–185. 22 indexed citations
16.
17.
Avivi, Irit, et al.. (2011). Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors. Annals of Hematology. 91(2). 215–221. 12 indexed citations
18.
Hardak, Emília, Gidon Berger, Norberto Krivoy, Anna Solomonov, & Mordechai Yigla. (2010). Nitrofurantoin Pulmonary Toxicity: Neglected Threat. Current Drug Safety. 5(2). 125–128. 4 indexed citations
19.
Hardak, Emília, Mordechai Yigla, Irit Avivi, et al.. (2009). Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome. Bone Marrow Transplantation. 44(9). 595–599. 20 indexed citations
20.
Yigla, Mordechai, Naveh Tov, Anna Solomonov, et al.. (2002). Bronchoscopic Procedures in the Diagnosis of Exophytic Endobronchial Malignant Neoplasms. Journal of Bronchology. 9(2). 102–107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026